Novel approach for influenza vaccination shows promise in early animal testing

May 22, 2013
When ferritin (gray) is fused with the influenza protein hemagglutinin (blue), it self-assembles into a sphere with eight protruding spikes from its surface. Credit: NIAID

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine concept, which was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), represents an important step forward in the quest to develop a universal influenza vaccine—one that would protect against most or all influenza strains without the need for an annual vaccination.

The scientists designed an experimental vaccine featuring the protein ferritin, which can self-assemble into microscopic pieces called nanoparticles, as a key component. Ferritin was fused genetically with hemagglutinin (HA), the protein found on the surface of the influenza virus, resulting in a nanoparticle with eight protruding viral spikes. Using this as the basis for the vaccine antigen, the researchers created an experimental vaccine using HA from a 1999 strain of H1N1 influenza virus and evaluated its ability to stimulate an immune response in mice. A single dose of the experimental vaccine both with and without the use of an adjuvant triggered an immune response in the mice comparable to two doses of the currently licensed seasonal . The experimental vaccine was also active against a wider range of H1N1 influenza than the licensed vaccine.

The researchers also tested the experimental vaccine's ability to protect ferrets from infection with a 2007 strain of H1N1 influenza virus – a strain it had not been specifically designed to prevent. One day after exposure to the virus, ferrets that had received the experimental vaccine had significantly lower influenza virus levels than those that were not immunized. According to the study authors, the concept works by stimulating antibodies that hitch themselves to the parts of the that stay consistent across different strains. Although further testing is needed, the HA-ferritin nanoparticle approach shows promise for development of more broadly protective vaccines for influenza as well as for other infectious diseases, the authors note.

More information: Kanekiyo M et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. DOI: 10.1038/nature12202

Related Stories

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.